Renaissance Technologies (RenTech)'s DRTS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 40,457 shares of Alpha Tau Medical Ltd. (DRTS) worth $286,031, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in DRTS, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 40,457 shares. Largest reduction occurred in Q4 2025, reducing 61,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Alpha Tau Medical (DRTS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Alpha Tau Medical (DRTS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +40,457 | New Buy | 40,457 | $7.07 |
| Q4 2025 | -61,900 | Sold Out | 0 | $0.00 |
| Q3 2025 | +32,500 | Add 110.54% | 61,900 | $4.51 |
| Q2 2025 | +29,400 | New Buy | 29,400 | $3.12 |
| Q1 2025 | -41,000 | Sold Out | 0 | $0.00 |
| Q4 2024 | +26,800 | Add 188.73% | 41,000 | $3.10 |
| Q3 2024 | +14,200 | New Buy | 14,200 | $2.38 |
| Q2 2024 | -14,700 | Sold Out | 0 | $0.00 |
| Q1 2024 | -9,900 | Reduce 40.24% | 14,700 | $2.93 |
| Q4 2023 | +24,600 | New Buy | 24,600 | $3.01 |
| Q4 2022 | -19,016 | Sold Out | 0 | $0.00 |
| Q3 2022 | +19,016 | New Buy | 19,016 | $5.84 |
Renaissance Technologies (RenTech)'s Alpha Tau Medical Investment FAQs
Renaissance Technologies (RenTech) first purchased Alpha Tau Medical Ltd. (DRTS) in Q3 2022, acquiring 19,016 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Alpha Tau Medical Ltd. (DRTS) for 12 quarters since Q3 2022.
Renaissance Technologies (RenTech)'s largest addition to Alpha Tau Medical Ltd. (DRTS) was in Q1 2026, adding 40,457 shares worth $286,031.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 40,457 shares of Alpha Tau Medical Ltd. (DRTS), valued at approximately $286,031.
As of the Q1 2026 filing, Alpha Tau Medical Ltd. (DRTS) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Alpha Tau Medical Ltd. (DRTS) was 61,900 shares, as reported at the end of Q3 2025.